Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Total Current Liabilities: 2015-2024

Historic Total Current Liabilities for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $111.0 million.

  • Wave Life Sciences' Total Current Liabilities fell 49.69% to $85.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.9 million, marking a year-over-year decrease of 49.69%. This contributed to the annual value of $111.0 million for FY2024, which is 40.49% down from last year.
  • Per Wave Life Sciences' latest filing, its Total Current Liabilities stood at $111.0 million for FY2024, which was down 40.49% from $186.4 million recorded in FY2023.
  • Over the past 5 years, Wave Life Sciences' Total Current Liabilities peaked at $186.4 million during FY2023, and registered a low of $64.2 million during FY2021.
  • Its 3-year average for Total Current Liabilities is $123.0 million, with a median of $111.0 million in 2024.
  • In the last 5 years, Wave Life Sciences' Total Current Liabilities plummeted by 46.96% in 2021 and then soared by 160.68% in 2023.
  • Over the past 5 years, Wave Life Sciences' Total Current Liabilities (Yearly) stood at $121.0 million in 2020, then plummeted by 46.96% to $64.2 million in 2021, then grew by 11.40% to $71.5 million in 2022, then spiked by 160.68% to $186.4 million in 2023, then tumbled by 40.49% to $111.0 million in 2024.